MediLumine Inc.

MediLumine is a biotechnology company dedicated to supporting scientists with tools for preclinical research and in vivo imaging. The company began in 2013 with the launch of the Fenestra® range of biomimetic contrast agents enabling tumor visualization and functional imaging of liver diseases in laboratory mice models of human diseases.
In line with our core values ​​of enabling “Vision without Sacrifice”, we now offer several imaging products, such as MediLumine’s PRISM™ range of in vivo imaging systems, designed for preclinical monitoring of physiological changes in living systems in the context of therapeutic discovery research.